STERIS signs $2.55 billion financing package in connection with acquisition of Cantel Medical

Client(s) STERIS plc

Jones Day represented STERIS plc, a leading provider of infection prevention and other procedural products and services, in connection with a new (i) $1.25 billion revolving credit facility, (ii) $550 million term loan facility, and (iii) $750 million delayed draw term loan facility with JPMorgan Chase Bank, N.A., as administrative agent, the proceeds of which will be used, in part, to finance the acquisition of Cantel Medical Corp, a global provider of infection prevention products and services primarily to endoscopy and dental customers.